Johannes Fruehauf

General Partner at Mission BioCapital

Johannes Fruehauf is the General Partner at Mission BioCapital. Previously, Johannes was the Founding Investor and Board Director at Tidal Therapeutics. Johannes holds an MD in Medicine from the Johann Wolfgang Goethe-Universität Frankfurt am Main.

Links

Previous companies

Sentien Biotech logo

Org chart

Timeline

  • General Partner

    Current role